We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hotline Part of New UK Anticounterfeit Strategy
Hotline Part of New UK Anticounterfeit Strategy
December 12, 2007
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) unveiled an aggressive agenda Nov. 23 for combating the market in counterfeit medicines and medical devices.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor